Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132996) titled 'Spleen Volume Change Predicts 45-Day Mortality in Neurocritical Care: A Prospective Cohort Study' on Aug. 11.
Study Type: Observational
Primary Sponsor: Ankara City Hospital Bilkent
Condition:
Intracerebral Hemorrhage (ICH)
Hemorrhagic Stroke, Intracerebral
Neurocritical Care
Acute Brain Injury
Ultrasound
Intervention:
Diagnostic Test: POCUS-based Splenic Volume Measurement
Recruitment Status: Not recruiting
Date of First Enrollment: March 15, 2024
Target Sample Size: 42
Countries of Recruitment:
Turkey
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07132996
Published by HT Digital Content Se...